AGRX stock forecast
Our latest prediction for Agile Therapeutics, Inc.'s stock price was made on the Feb. 25, 2020 when the stock price was at 3.02$.
In the short term (2weeks), AGRX's stock price should outperform the market by 3.78%. During that period the price should oscillate between -10.74% and +16.80%.
In the medium term (3months), AGRX's stock price should underperform the market by -2.22%. During that period the price should oscillate between -40.22% and +40.60%.Get email alerts
About Agile Therapeutics, Inc.
Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patch. Its lead product candidate, Twirla, also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. The company was founded by Chien Te Yen on December 22, 1997 and is headquartered in Princeton, NJ.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.38$ per share.
The book value per share is 0.76$
Three months stock forecastFeb. 25, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|